Maximus runs government health and human services programmes under contract, including benefits administration, call centres and eligibility systems for US federal and state agencies. Long contracts and the difficulty of replacing an incumbent operator provide stable revenue. Growth depends on new awards and the rebid cycle. Revenue fell 5.1%, but ROE is 21.1% and the trailing multiple is 8.6x, against a forward multiple of 19.1x that implies lower earnings ahead.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 21 Oct 2026, 11:06 CEST | Rating | Undervalued | first publication | $61.09 |
| 21 Oct 2026, 11:06 CEST | Fair value | $106 | $111 | $61.09 |
| 18 Oct 2026, 01:52 CEST | ACCE price target | $74.00 | $60.00 | $61.47 |
| 16 Oct 2026, 00:00 CEST | Fair value | $111 | $112 | $57.76 |
| 12 Oct 2026, 00:00 CEST | Fair value | $112 | $76.86 | $59.39 |
| 8 Oct 2026, 00:00 CEST | Fair value | $76.86 | $87.48 | $54.68 |
| 5 Oct 2026, 00:00 CEST | Fair value | $87.48 | $88.94 | $52.65 |
| 1 Oct 2026, 00:00 CEST | Fair value | $88.94 | $75.82 | $53.07 |
| 28 Sept 2026, 00:00 CEST | ACCE price target | $60.00 | first publication | $52.61 |
| 26 Sept 2026, 00:00 CEST | Fair value | $75.82 | $88.35 | $52.62 |
Answered from Maximus Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| MMS Maximus Inc. Common Stock | $63.02 | $106 | 40% below | 9.4x | 21.1% | 64 | 54 |
| ABM ABM Industries Incorporated Common Stock | $53.67 | $52 | 3% above | 19.4x | 9.2% | 35 | 65 |
| MTO.L Mitie Group plc | £2.11 | £2 | 8% above | 35.1x | 18.8% | 45 | 63 |
| SRP.L Serco Group plc | £2.81 | £4 | 24% below | 18.8x | 17.6% | 44 | 59 |
| CBZ CBIZ Inc. Common Stock | $54.94 | $50 | 9% above | 23.1x | 6.5% | 43 | 51 |
| FA First Advantage Corporation Common Stock | $21.25 | $16 | 31% above | 151.8x | 1.9% | 41 | 68 |
| AZZ AZZ Inc. | $132.36 | $109 | 22% above | 23.8x | 12.3% | 64 | 63 |
Where MMS ranks against its sector peers on each metric.